HIGHFDA DEVICE

C-RAD POSITIONING AB Recalls Catalyst Device Over Treatment Risks

C-RAD POSITIONING AB recalled 189 Catalyst and Catalyst+ devices on October 9, 2025, due to issues with stereotactic radiosurgery (SRS) treatment. The defect may lead to incorrect patient positioning, potentially compromising treatment effectiveness. The recall affects devices distributed across 37 countries, including the United States.

Official notice
C-RAD POSITIONING ABHealth & Personal CareMedical DevicesLot Code: Note: The error is not related to any serial numbers or LOT numbers. The error is limited to the software module cSRS in combination with cMotion module

Source-backed recall notice

No product image was available from the source feed.

Official source
FDA DEVICE
Recall date
October 9, 2025
Status
ACTIVE
Severity
8/10

Quick Facts at a Glance

Recall Date
October 9, 2025
Hazard Level
HIGH
Brand
C-RAD POSITIONING AB
Category
Health & Personal Care
Sold At
Multiple Retailers
Geographic Scope
1 states
At-Risk Groups
GENERAL

What to Do Now

Use this page like a recall checklist: verify the product first, then act on the official remedy.

Immediate steps

  1. 1Stop using the product until you confirm whether it is included in the recall.
  2. 2Compare the product label, model number, UPC, color, size, and purchase location against the identifiers below.
  3. 3Follow the official remedy from FDA - Medical Devices; save photos, receipts, labels, and correspondence before contacting the company.
  4. 4If the product could harm a child, older adult, pet, or patient, move it out of reach immediately.

Check these identifiers

Brand
C-RAD POSITIONING AB
Product type
Patient Positioning Device
Model numbers
Lot Code: Note: The error is not related to any serial numbers or LOT numbers. The error is limited to the software module cSRS in combination with cMotion module
Sold at
Multiple Retailers
Where affected
ALL

Recall Timeline

Key dates and source checks for this recall record.

  1. Recall announced

    October 9, 2025

  2. Reported by FDA DEVICE

    January 21, 2026

  3. RecallRadar source check

    January 28, 2026

  4. Consumer action

    Use the official remedy and keep documentation.

Hazard Information

Due to issues with the system's stereotactic radiosurgery (SRS) treatment cannot be guaranteed for all couch angles and system setups. n certain cases, the system may indicate the patient as correctly positioned at the isocenter, even when the isocenter is positioned outside of the indicated tolerance.

What You Should Do

Patients and healthcare providers should stop using this device immediately. Follow the recall instructions provided by the manufacturer. Contact C-RAD POSITIONING AB or your healthcare provider for instructions. Notification method: Letter

About This Product

The Catalyst and Catalyst+ devices are used for patient positioning in diagnostic imaging and radiotherapy, particularly in stereotactic radiosurgery. They help ensure accurate targeting during treatment.

Why This Is Dangerous

The issue arises from the software module that may incorrectly indicate proper patient positioning, potentially leading to ineffective treatment outcomes.

Industry Context

This recall is not part of a broader industry pattern.

Real-World Impact

Patients and healthcare providers must cease using the device immediately to avoid potential treatment risks.

Practical Guidance

How to identify if yours is affected

  1. Check the model number on the device for SP001-0026 or SP003-0002.
  2. Confirm the presence of the cSRS software module in combination with cMotion module.
  3. Consult healthcare provider for guidance on affected devices.

Where to find product info

Model numbers and software versions can usually be found on the device label or user manual.

What timeline to expect

Expect a response for refund processing within 4-6 weeks after contacting the manufacturer.

If the manufacturer is unresponsive

  • Follow up with C-RAD POSITIONING AB via phone or email.
  • Consider contacting regulatory authorities if issues persist.

How to prevent similar issues

  • Research safety certifications for medical devices before purchase.
  • Consult healthcare professionals for device recommendations.
  • Stay informed about product recalls in the medical device sector.

Documentation advice

Keep records of your communications with the manufacturer, including dates and details.

Get instant alerts for Health & Personal Care recalls

Be the first to know. Free instant alerts to your inbox.

No spamUnsubscribe anytime

Product Details

The recalled models are Catalyst (SP001-0026) and Catalyst+ (SP003-0002). These devices include the cSRS module used in combination with the cMotion module. The devices were distributed across 37 countries, including the U.S. states of AK, AL, AR, CA, CT, FL, MO, NC, NM, NY, OH, OK, OR, PA, TN, TX, VA, and WA.

Key Facts

  • Recall date: October 9, 2025
  • Quantity recalled: 189 units
  • Hazard classification: Class II
  • Risk level: High

Safety Guide

Not sure what to do next? Our guide walks you through the process step by step.

Read: What to Do When You Find a Recalled Product

Get Alerts for Health & Personal Care Recalls

Get instant alerts for recalls that affect you. Free forever.

Safety Assessment

Risk LevelHIGH
Severity Score
8/ 10
Affected Groups
GENERAL
Injury Types
OTHER

Product Classification

Product TypePatient Positioning Device
Sold At
Multiple Retailers

Product Details

Model Numbers
Lot Code: Note: The error is not related to any serial numbers or LOT numbers. The error is limited to the software module cSRS in combination with cMotion module
Affected States
ALL
Report Date
January 21, 2026
Recall Status
ACTIVE

Related Recalls

Health & Personal Care
MEDIUM

Taro Pharmaceuticals Withdraws Diclofenac Sodium Gel Over Viscosity Issues

Taro Pharmaceuticals announced a market withdrawal of Diclofenac Sodium, Topical Gel, 3% on January 27, 2026. The withdrawal stems from out of specification viscosity results. Healthcare providers and consumers should stop using the product immediately.

BEEKEEPER'S NATURALS USA
Microbial Contamination
Read more
Health & Personal Care
MEDIUM

AvKARE Recalls Rosuvastatin Tablets Due to Dissolution Issues

AvKARE recalled 7,991 cartons of Rosuvastatin Tablets on December 31, 2025. The recall stems from the product being out of specification for dissolution. Consumers should stop using the medication immediately and consult healthcare providers for guidance.

SUN PHARMACEUTICAL INDUSTRIES
Labeling: Not
Read more